Urological disorders immunotherapeutic (AmVac)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameUrological disorders immunotherapeutic (AmVac)
Drug Alias Name泌尿系统疾病的免疫治疗 – AmVacProstaVacAMV-110
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsProstatitisProstatic Hyperplasia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesVakcina Kft
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVakcina KftAmvac Kft
Active IndicationsN/A
Inactive IndicationsProstatitisProstatic Hyperplasia

Other Information

ATC CodeN/A
Related LinksN/A